Breast cancer
Conditions
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients must provide informed consent for the study voluntarily and possess the capacity for autonomous decision-making, signing the informed consent form within 30 days prior to enrollment. (2) Pathological confirmation of primary breast cancer. (3) Received curative surgery for the primary site. (4) Indication for adjuvant radiotherapy to the breast. (5) Necessary assessments and examinations before treatment must be completed prior to enrollment. (6) Willing and able to participate in regular follow-up.
Exclusion criteria
Exclusion criteria: (1) Intended for external regional irradiation of the breast. (2) Serious medical conditions that could significantly affect compliance with the clinical trial, such as unstable heart disease, kidney disease, chronic hepatitis, poorly controlled diabetes, and psychiatric disorders, among others. (3) Other situations in which researchers deem the individual unsuitable for participation in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival, PFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Local control rate;Overall survival;Disease free survival, DFS;Distant metastasis-free survival, DMFS; | — |
Countries
China
Contacts
Public ContactZhikai Liu
Peking Union Medical College Hospital
Outcome results
None listed